A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β

Clinton Yam, Rashmi K. Murthy, Gaiane M. Rauch, James L. Murray, Ronald S. Walters, Vicente Valero, Abenaa M. Brewster, Robert C. Bast, Daniel J. Booser, Sharon H. Giordano, Francisco J. Esteva, Wei Yang, Gabriel N. Hortobagyi, Stacy L. Moulder, Banu Arun

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of imatinib mesylate and letrozole in patients with hormone receptor-positive metastatic breast cancer expressing c-kit or PDGFR-β'. Together they form a unique fingerprint.

Medicine & Life Sciences